Skip to main content

Table 1 Participant characteristics overall and stratified by metabolic syndrome status

From: Substituting device-measured sedentary time with alternative 24-hour movement behaviours: compositional associations with adiposity and cardiometabolic risk in the ORISCAV-LUX 2 study

 

All (n = 1046)

No metabolic syndrome (n = 768)

Metabolic syndrome (n = 278)

p-value

Sex

 Male

486 (46.5)

322 (41.9)

164 (59.0)

 

 Female

560 (53.5)

446 (58.1)

114 (41.0)

 < 0.001

Age (y)

51.2 ± 12.2

48.7 ± 11.7

58.1 ± 10.8

 < 0.001

Education level

 Higher education

456 (43.6)

371 (48.3)

85 (30.6)

 

 High school

443 (42.3)

315 (41.0)

128 (46.0)

 

 No diploma

147 (14.1)

82 (10.7)

65 (23.4)

 < 0.001

Smoking status

 Never

626 (59.8)

481 (62.6)

145 (52.2)

 

 Former

300 (28.7)

208 (27.1)

92 (33.1)

 

 Current

120 (11.5)

79 (10.3)

41 (14.7)

0.007

Use of antihypertensive, diabetes and/or lipid-lowering medication

 No

747 (71.4)

655 (85.3)

92 (33.1)

 

 Yes

299 (28.6)

113 (14.7)

186 (66.9)

 < 0.001

Family history of CVD or diabetes

 No

687 (65.7)

523 (68.1)

164 (59.0)

 

 Yes

314 (30.0)

218 (28.4)

96 (34.5)

 

 Unknown

45 (4.3)

27 (3.5)

18 (6.5)

0.010

Energy intake (kcal/day)

2362 (1848 to 2974)

2284 (1806 to 2901)

2557 (1996 to 3136)

 < 0.001

Salt (g/day)

8.2 (6.2 to 11.0)

8.1 (6.0 to 10.7)

8.9 (6.9 to 11.8)

 < 0.001

Caffeine (mg/day)

308.1 ± 313.6

298.6 ± 307.7

334.2 ± 328.5

0.06

Depressive symptoms

8 (4 to 14)

8 (4 to 14)

9 (4 to 15)

0.085

Sleep quality

5 (4 to 8)

5 (4 to 8)

5 (4 to 8)

0.45

General health

78 (70 to 86)

78 (70 to 86)

74 (62 to 82)

 < 0.001

Season

    

 summer

237 (22.7)

176 (22.9)

61 (21.9)

 

 autumn

278 (26.6)

202 (26.3)

76 (27.3)

 

 winter

282 (26.9)

209 (27.2)

73 (26.3)

 

 spring

249 (23.8)

181 (23.6)

68 (24.5)

0.96

Waist circumference (cm)

89.8 ± 13.4

85.7 ± 11.3

101.2 ± 12.0

 < 0.001

Systolic blood pressure (mmHg)

124.1 ± 16.8

120.5 ± 16.3

134.1 ± 13.9

 < 0.001

Diastolic blood pressure (mmHg)

78.4 ± 10.8

76.3 ± 10.1

84.1 ± 10.4

 < 0.001

Fasting glucose (mg/dL)

92.5 ± 13.2

88.6 ± 8.3

103.4 ± 17.6

 < 0.001

Triglycerides (mg/dL)

88 (65 to 118)

80 (60 to 104)

123 (89 to 168)

 < 0.001

HDL-c (mg/dL)

57.8 ± 14.2

60.9 ± 13.5

49.1 ± 12.5

 < 0.001

CCMR (z-score)

0.00 ± 3.4

− 1.3 ± 2.7

3.6 ± 2.8

 < 0.001

Total body fat (%)

28.3 ± 8.6

26.9 ± 8.5

32.1 ± 7.8

 < 0.001

Fasting insulin (μIU/mL)

6.9 (5.1 to 9.6)

6.2 (4.7 to 8.0)

10.9 (7.6 to 14.9)

 < 0.001

ApoB/A1 ratio

0.58 ± 0.17

0.56 ± 0.16

0.65 ± 0.19

 < 0.001

  1. Data are n (%) for categorical variables, mean ± standard deviation for normally distributed variables, and median (IQR) for non-normally distributed variables. P-values represent a test of group differences by metabolic syndrome status performed using chi-square tests, ANOVA or Kruskal–Wallis tests as appropriate. Bold font signifies statistically significant group differences (p < 0.05). Data for total body fat was available for n = 1025 participants (no metabolic syndrome: n = 751; metabolic syndrome: n = 274).
  2. ApoB/A1 Apolipoprotein B to A1, CCMR Clustered cardiometabolic risk, HDL-c High-density lipoprotein cholesterol